首页|期刊导航|麻醉安全与质控|围手术期用药安全的多维防控与标准化实践

围手术期用药安全的多维防控与标准化实践OA

Multidimensional prevention and control and standardized practice for perioperative medication safety

中文摘要英文摘要

围手术期用药安全是麻醉学科质量与患者安全管理的核心内容.用药错误(ME)在该阶段的发生风险较高且具有可预防性.ME 不仅可能导致治疗失败,还可显著增加围手术期医疗风险.本文基于国内外最新循证医学证据及专家共识,深入剖析了围手术期ME 的成因、防控逻辑与体系构建路径,从人为因素、系统缺陷、药品特性及特殊人群管理不足等方面进行分析,并提出"人员—流程—技术—管理"四维防控体系:通过强化人员胜任力与安全文化建设,优化标准化闭环流程,推动智能化技术应用,以及实施精细化管理策略,实现用药安全的多维防护.本文进一步以 ISO 26825 彩色标签标准化为例,探讨了基于人因工程学的低成本干预措施在临床实践中的应用价值.最后,结合智慧医疗发展趋势,对未来智能药柜深度整合、区域同质化建设及多中心数据共享等前沿方向进行了展望,旨在推动围手术期用药安全由经验驱动向标准驱动转变,为临床提供科学、系统的管理路径.

Perioperative medication safety constitutes a core component of quality and patient safety management in anesthesiology.Medication errors(ME)carry a high risk of occurrence during this phase,yet they are largely preventable.Such errors may not only lead to treatment failure but also significantly increase perioperative medical risks.Based on the latest domestic and international evidence-based medical evidence and expert consensus,this paper provides an in-depth analysis of the etiology,prevention and control logic,and system construction pathways of perioperative ME.It examines contributing factors including human factors,system deficiencies,drug characteristics,and inadequate management of special populations.A four prevention-and-control framework of personnel–process–technology–management is proposed:multi‑dimensional protection for medication safety can be achieved by strengthening personnel competency and safety-culture development,optimizing standardized closed-loop workflows,promoting the adoption of intelligent technologies,and implementing refined management strategies.Taking the standardization of ISO 26825 colour-coding labels as an example,this paper further discusses the practical value of low‑cost human‑factors‑engineering‑based interventions in clinical settings.Finally,in light of trends in smart-healthcare development,forward-looking perspectives are presented on cutting-edge directions such as deep integration of intelligent medication cabinets,regional homogenized construction,and multi-center data sharing.This study aims to shift perioperative medication-safety management from experience-driven to standard-driven practice,providing a scientific and systematic management pathway for clinical practice.

褚华清;郑晖

国家癌症中心 国家肿瘤临床医学研究中心 中国医学科学院北京协和医学院肿瘤医院麻醉科,北京 100021国家癌症中心 国家肿瘤临床医学研究中心 中国医学科学院北京协和医学院肿瘤医院麻醉科,北京 100021

围手术期用药安全用药错误麻醉彩色标签多维防控

perioperative periodmedication safetymedication errorsanesthesiacolor-coded labelsmultidimensional prevention and control

《麻醉安全与质控》 2026 (5)

407-411,5

中央高水平医院临床科研业务费资助(80102022619)

10.3969/j.issn.2096-2681.2026.05.003

评论